NTBL - Notable Labs Quarterly EPS earnings growth

Notable Labs Ltd - graphic logo of issuer NTBL

The quarterly shift in earnings per share illustrates EPS dynamics, where the 0.00 mark characterizes this parameter. Notable Labs, Ltd. (NTBL) operates independently of market cycles due to stable demand for diagnostics. The company is implementing the PPMP IT system to analyze therapy on patient cells. High physician confidence in AI technologies solidifies the brand's status as a promising venture project.

Notable Labs (NTBL) Year-over-year earnings per share growth for the last 12 months: for the period 02/21/2024 - 11/02/2024

Notable Labs, Ltd. - analytical breakdowns and key metrics (NTBL)

- market value and analyst target forecast:
Initial company analysis:Notable Labs Inc. - NTBL
Finished products of Notable Labs Corp

This indicator assesses net earnings per share dynamics by measuring quarterly growth rates to determine capital management efficiency. By analyzing the quarterly EPS growth trajectory, investors can see how Notable Labs, Ltd. (NTBL) converts cost optimization for oncology software and cloud system energy efficiency into real yield growth, eliminating time lags between financial reports.

Direct competitors

ONC: Quarterly EPS earnings growth|Halozyme Inc. - Year-over-year earnings per one share growth for the last 12 months|RVMD (Revolution Medicines Inc) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Ascentage Pharma Group AAPG|Quarterly EPS earnings growth CGON|Quarterly EPS earnings growth UroGen Pharma Ltd (URGN)|Quarterly EPS earnings growth BCAX (Bicara Corp)|Personalis Genomics (PSNL) - Earnings per share growth in annualized terms for the last twelve months|Erasca Oncology - Quarterly EPS earnings growth|DCTH: Year-over-year earnings per share growth for the last twelve months|YMAB: Quarterly EPS earnings growth|Aura Bio (AURA) - Quarterly EPS earnings growth|CADL (Candel Therapeutics Inc.) - Quarterly EPS earnings growth|ARAY: Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months SLS (SELLAS Life Sciences Group, Inc.)|Year-over-year earnings per share growth rate for the last twelve months ACTU|Citius Oncology - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months HURA|TARA: Year-over-year net earnings per share growth for the last 12 months|Earnings per share growth in annualized terms for the last twelve months Fate Pharma|Aadi Bioscience Inc (WHWK) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months TScan (TCRX)|Year-over-year net earnings per share growth for the last 12 months CSBR|xbiotech.com (XBIT) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months cel-sci.com (CVM)|OSTX - Earnings per share growth in annualized terms for the last twelve months|Radiopharm Theranostics - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months ARTV|ANL - Year-over-year earnings per share growth for the last twelve months|VERU - Quarterly EPS earnings growth|Tempest Therapeutics, Inc. (TPST) - Year-over-year earnings per share growth for the last twelve months|XLO: Year-over-year earnings per share growth rate for the last twelve months|RENB (Renovaro Biosciences) - Quarterly EPS earnings growth|MURA: Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months KAPA (Kairos Pharma Ltd)|Year-over-year earnings per share growth rate for the last twelve months OKUR|CytoMed Therapeutics Limited - Year-over-year net earnings per share growth for the last 12 months|CRIS: Year-over-year earnings per share growth for the last 12 months|APLM - Year-over-year earnings per share growth for the last twelve months|THAR - Quarterly EPS earnings growth|ADVB: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months GNPX|CLDI (Calidi Biotherapeutics, Inc.) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months SBFM|Quarterly EPS earnings growth XBIO|Year-over-year net earnings per share growth for the last 12 months Salarius Pharmaceuticals SLRX|Quarterly EPS earnings growth PPBT (Purple Biotech Ltd)|AONC - Year-over-year net earnings per share growth for the last 12 months|BGNE: Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share change for the last twelve months Checkpoint Therapeutics, Inc CKPT|ELEV: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months iCAD Inc. (ICAD)|IKNA (Ikena) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months Viracta Therapeutics (VIRX)|Year-over-year earnings per share growth for the last twelve months MorphoSys Corporation (MOR)|NAYA (NAYA Biosciences) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth AAPGV (Ascentage)